The purchase of this acquisition is to purchase one (1) syntax system model 200 instrument model STX-200
Ended Purchase Order Awarded Last action
- Contract number
- 75N93024P01215
- Awardee
-
DNA Script Inc. UEI V5JNJ33ZCSM3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $342,026
Award facts
- Opportunity
-
- Syntax System Model 200 Instruments- Brand Name or Equal Pre-Solicitation · RFQNIAID242224327 · Posted Aug 2, 2024
- Contract value 100% obligated
- $342,026.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Colma, CA 94014, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $342,026 |
About this award
This federal contract award is for the purchase of one (1) Syntax System Model 200 instrument for the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Production Program (VPP). The total ceiling value of the firm-fixed-price purchase order is $342,026.40. The contractor, DNA Script Inc., is a foreign-owned for-profit business that provides advanced DNA synthesis technologies and associated products and services to U.S. government agencies. This procurement was not set aside for any specific business category, and the requirement was initially released as a Sources Sought notice to identify qualified vendors. The Syntax System 200 will be used to produce 96 x 120 nucleotide base oligonucleotides, which will be leveraged to create genes encoding vaccines or biotherapeutic candidates for NIAID's research and development activities.
Quick answers
Who was awarded contract 75N93024P01215?
75N93024P01215 was awarded to DNA Script Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 26, 2024.
How much is contract 75N93024P01215 worth?
The government has obligated $342,026 on 75N93024P01215.
Was contract 75N93024P01215 competed?
The extent of competition for 75N93024P01215 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award